Perspective Article

Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal

National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MA, USA
Etablissement Français du Sang, INSERM U955, Université Paris Est Créteil, Créteil, France;Laboratoire d’Excellence GR-Ex, Paris, France
Center for Transfusion Medicine and Cellular Therapies, Department of Laboratory Medicine and Pathology, Emory University School of Medicine, Atlanta, GA, USA;Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA
Laboratoire d’Excellence GR-Ex, Paris, France;Sickle Cell Referral Center, Department of Internal Medicine, Henri-Mondor University Hospital– UPEC, AP-HP, Créteil, France
Sickle Cell Referral Center, Department of Internal Medicine, Henri-Mondor University Hospital– UPEC, AP-HP, Créteil, France
Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA
Departments of Laboratory Medicine and Pediatrics, Yale University School of Medicine, New Haven, CT, USA
Center for Transfusion Medicine and Cellular Therapies, Department of Laboratory Medicine and Pathology, Emory University School of Medicine, Atlanta, GA, USA
Vol. 105 No. 3 (2020): March, 2020 https://doi.org/10.3324/haematol.2019.224709